Skip to content

Predicting cancer therapy-related thrombocytopenia in pediatric patients

Predicting cancer therapy-related thrombocytopenia in pediatric patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400090736
Enrollment
Unknown
Registered
2024-10-12
Start date
2023-11-01
Completion date
Unknown
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric Cancer

Interventions

Trail group:None

Sponsors

Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. 7 = Age = 18 years old; 2. At the time of diagnosis, there were no obvious abnormalities in organ function damage and no serious complications; 3. Complete one or more cycles of chemotherapy in this hospital.

Exclusion criteria

Exclusion criteria: 1. Refuse to complete informed consent; 2. Serious lack of research related data (= 50%); 3. Those who have not completed the chemotherapy course, including children who have given up treatment and request automatic discharge; 4. There are other possible causes of thrombocytopenia or the use of non chemotherapy drugs that may cause thrombocytopenia.

Design outcomes

Primary

MeasureTime frame
platelet count;

Secondary

MeasureTime frame
bleeding;hemoglobin;

Countries

China

Contacts

Public ContactChen Lin

Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine

chen-lin@scmc.com.cn+86 150 2662 5985

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026